Business / Finance

RSS

RXi closes exclusive global license agreement with Hapten Pharmaceuticals for Samcyprone

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapies addressing high-unmet medical needs, today announced the closing of its previously disclosed exclusive global license agreement for the therapeutic use of Samcyprone with Hapten Pharmaceuticals, LLC.

5 Feb 2015

USANA Health Sciences Singapore obtains CaseTrust accreditation

The USANA Health Sciences Singapore office recently had their business practices accredited by CaseTrust, the accreditation arm of the Consumers Association of Singapore (CASE). The initiative, which is led by the Direct Selling Association of Singapore, was kicked off in January 2014 with the intention to bring the standards of the direct selling industry in Singapore to a higher standard.

5 Feb 2015

Misonix net sales increase 36% to $5.6 million in second quarter fiscal 2015

Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the second quarter of fiscal 2015, ended December 31, 2014.

5 Feb 2015

Welch Allyn partners with Nonin Medical to provide clinically-proven PureSAT SpO2 technology

Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today announced it has partnered with Nonin Medical, a leader in designing and manufacturing noninvasive medical monitoring solutions, to provide its clinically-proven PureSAT SpO2 technology.

4 Feb 2015

PRO-DEX completes acquisition of Fineline Molds

PRO-DEX, INC. today announced that on February 1, 2015 it completed its acquisition of substantially all of the assets of Fineline Molds, a company located in San Dimas, Calif. that manufactures plastic injection molding tools.

4 Feb 2015

BioClinica reports 2014 as record year for its eClinical technologies business unit

BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that 2014 was a record year for its eClinical technologies business unit, with sales soaring 51 percent above the previous year.

From Clario 4 Feb 2015

Edwards Lifesciences’ net sales increase 15% to $618.0M in Q4 2014

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended December 31, 2014 of $109.2 million, or $1.00 per diluted share, and non-GAAP1 net income of $116.5 million, or $1.06 per diluted share. Net income for the same period a year earlier was $75.1 million, or $0.68 per diluted share, and non-GAAP net income was $105.0 million, or $0.95 per diluted share.

4 Feb 2015

Omnicell's revenue increases 8.0% to $121.5 million in fourth quarter 2014

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced results for its fourth quarter and year ended December 31, 2014.

From Omnicell, Inc. 4 Feb 2015

EyeBrain raises €1.3 million ($1.47 million) through crowdfunding

EyeBrain, a company that develops markers of cerebral function for neurological and psychiatric disorders and diseases, today announces the conclusion of a new round of funding. A total of €1.3 million ($1.47 million) has been raised with the support of EyeBrain’s shareholders, the Fonds Régional de Co-Investissement d’Ile-de-France (FRCI, regional joint investment fund for the Ile-de-France or Greater Paris area) and the Anaxago crowdfunding platform.

4 Feb 2015

Cphi partners with InformEx to launch new InformEx cGMP Zone at 2015 show

CPhI, the leading global sourcing event for the pharmaceutical industry, is partnering with InformEx to launch the new, InformEx cGMP Zone at the 2015 show (3-5th February in New Orleans).

4 Feb 2015

Cardinal Health approves quarterly dividend of $0.3425 per share

Cardinal Health today announced that its board of directors approved a quarterly dividend of $0.3425 per share.

4 Feb 2015

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

BioMed Realty Trust, Inc. today announced that it is under contract to acquire the 307 Westlake Avenue North building in the heart of the burgeoning South Lake Union life science market of Seattle, Washington for approximately $90 million.

4 Feb 2015

Neovasc closes underwritten public offering of common stock

Neovasc Inc. is pleased to announce the closing of its previously announced underwritten public offering of 12,075,000 common shares of the Company at a price per share of US$7.19 (the "Offering") for aggregate gross proceeds of approximately US$74,883,850 for the Company and US$11,935,400 for the Selling Securityholders (as defined below) before deducting underwriting discounts and commissions and offering expenses payable by the Company and the Selling Securityholders.

4 Feb 2015

Healthcare Realty Trust announces common stock cash dividend for Q4 2014

Healthcare Realty Trust Incorporated today announced its common stock cash dividend for the quarter ended December 31, 2014.

4 Feb 2015

HealthSouth agrees to acquire Cardinal Hill Rehabilitation Hospital from Kentucky Easter Seal Society

HealthSouth Corporation today announced it has entered into an agreement to purchase Cardinal Hill Rehabilitation Hospital in Lexington, Kentucky, from the Kentucky Easter Seal Society, Inc.

3 Feb 2015

Three CRO Enterprise Partners expand agreements with DATATRAK

DATATRAK International, Inc., the leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced three CRO Enterprise Partners have expanded their agreements. These industry-leading organizations have chosen to boost their global licensing capacity and extended their relationship with DATATRAK.

3 Feb 2015

Serum Institute of India to use Genticel's Vaxiclase platform to develop pertussis vaccines

Genticel, a French biotechnology company and leading developer of therapeutic vaccines, today announces that it has licensed its Vaxiclase technology to Serum Institute of India Ltd., for use as a component in acellular multivalent combination vaccines including pertussis antigens.

3 Feb 2015

Ildong Pharmaceutical to market BELVIQ (lorcaserin HCl) for weight management in South Korea

Arena Pharmaceuticals, Inc. today announced that Ildong Pharmaceutical Co., Ltd., has informed Arena that the Ministry of Food and Drug Safety has approved BELVIQ (lorcaserin HCl) for marketing for weight management in South Korea. Ildong will market and distribute BELVIQ in South Korea under its marketing and supply agreement with Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, or Arena GmbH.

3 Feb 2015

BioTrackTHC, Adherence Colorado form strategic alliance

BioTrackTHC, the top provider of seed-to-sale software solutions for medical and retail marijuana businesses, today announced a strategic alliance with Adherence Colorado, the leading provider of compliance audits and inventory reconciliation for the cannabis industry.

3 Feb 2015

Theravance Biopharma, Mylan partner to develop and commercialize TD-4208 for COPD treatment

Theravance Biopharma, Inc. and Mylan Inc. today announced that the two companies will partner on the development and, subject to FDA approval, commercialization of TD-4208, a novel investigational once-daily nebulized long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD) and other respiratory diseases.

2 Feb 2015

Business / Finance

RXi closes exclusive global license agreement with Hapten Pharmaceuticals for Samcyprone

USANA Health Sciences Singapore obtains CaseTrust accreditation

Misonix net sales increase 36% to $5.6 million in second quarter fiscal 2015

Welch Allyn partners with Nonin Medical to provide clinically-proven PureSAT SpO2 technology

PRO-DEX completes acquisition of Fineline Molds

BioClinica reports 2014 as record year for its eClinical technologies business unit

Edwards Lifesciences’ net sales increase 15% to $618.0M in Q4 2014

Omnicell's revenue increases 8.0% to $121.5 million in fourth quarter 2014

EyeBrain raises €1.3 million ($1.47 million) through crowdfunding

Cphi partners with InformEx to launch new InformEx cGMP Zone at 2015 show

Cardinal Health approves quarterly dividend of $0.3425 per share

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

Neovasc closes underwritten public offering of common stock

Healthcare Realty Trust announces common stock cash dividend for Q4 2014

HealthSouth agrees to acquire Cardinal Hill Rehabilitation Hospital from Kentucky Easter Seal Society

Three CRO Enterprise Partners expand agreements with DATATRAK

Serum Institute of India to use Genticel's Vaxiclase platform to develop pertussis vaccines

Ildong Pharmaceutical to market BELVIQ (lorcaserin HCl) for weight management in South Korea

BioTrackTHC, Adherence Colorado form strategic alliance

Theravance Biopharma, Mylan partner to develop and commercialize TD-4208 for COPD treatment

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News